Avalo Therapeutics (AVTX) Prepaid Assets (2014 - 2026)
Avalo Therapeutics posted quarterly Prepaid Assets of $6.7 million for Q1 2026, up 264.7% year-on-year from $1.8 million in Q1 2025, and down 3.3% on a QoQ basis from $6.9 million in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Prepaid Assets data on file, last reported at $6.7 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 264.7% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (up 264.7% YoY), and the FY2025 full-year result was $6.9 million, up 59.84% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.7 million, down from $6.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.9 million in Q4 2025 and bottomed at $100000.0 in Q1 2024.
- The 5-year median for Prepaid Assets is $1.6 million (2023), against an average of $2.1 million.
- The widest annual swing landed in 2024, when Prepaid Assets slumped 93.85%; it then soared 1803.0% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $1.3 million in 2022, then sank by 61.24% to $500000.0 in 2023, then jumped by 765.0% to $4.3 million in 2024, then surged by 59.84% to $6.9 million in 2025, then slipped by 3.3% to $6.7 million in 2026.
- The last three Prepaid Assets figures came in at $6.7 million (Q1 2026), $6.9 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.69 Mn |
| Dec 31, 2025 | 6.91 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 940,000.00 |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 2.68 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.75 Mn |
| Mar 31, 2021 | 2.47 Mn |
| Dec 31, 2020 | 2.66 Mn |
| Sep 30, 2020 | 1.54 Mn |
| Jun 30, 2020 | 823,900.00 |
| Mar 31, 2020 | 777,442.00 |
| Dec 31, 2019 | 706,968.00 |
| Sep 30, 2019 | 1.67 Mn |
| Jun 30, 2019 | 865,062.00 |
| Mar 31, 2019 | 1.25 Mn |
| Dec 31, 2018 | 731,954.00 |
| Sep 30, 2018 | 1.26 Mn |
| Jun 30, 2018 | 954,454.00 |
| Mar 31, 2018 | 774,310.00 |
| Dec 31, 2017 | 703,225.00 |
| Sep 30, 2017 | 341,025.00 |
| Jun 30, 2017 | 402,294.00 |
| Mar 31, 2017 | 249,603.00 |
| Dec 31, 2016 | 391,253.00 |
| Sep 30, 2016 | 210,023.00 |
| Jun 30, 2016 | 541,962.00 |
| Mar 31, 2016 | 231,541.00 |
| Dec 31, 2015 | 401,550.00 |
| Sep 30, 2015 | 105,059.00 |
| Dec 31, 2014 | 360,307.00 |